Extensive epidemiological data from diverse populations provide compelling real-world evidence for the critical role of aflatoxin-induced p53 alterations, particularly in conjunction with HBV infection, in driving HCC [18,25,26,27,28]. This evidence concerns the gene TP53 and hepatocellular carcinoma.